Evidence map›Paper›PMID 31156028›Full record

ArticlemAbs

Rapid global characterization of immunoglobulin G1 following oxidative stress.

Yao Chen, Emma Doud, Todd Stone, Lun Xin, Wei Hong, Yunsong Li

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Yao Chena Process Development, Catalent Pharma Solutions, Inc , Bloomington , IN , USA.
Emma Douda Process Development, Catalent Pharma Solutions, Inc , Bloomington , IN , USA.
Todd Stonea Process Development, Catalent Pharma Solutions, Inc , Bloomington , IN , USA.ORCID 0000-0001-9895-4651
Lun Xina Process Development, Catalent Pharma Solutions, Inc , Bloomington , IN , USA.
Wei Honga Process Development, Catalent Pharma Solutions, Inc , Bloomington , IN , USA.ORCID 0000-0002-2014-4672
Yunsong Lia Process Development, Catalent Pharma Solutions, Inc , Bloomington , IN , USA.
Catalent (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although peroxide and leachable metal-induced chemical modifications are among the most important quality attributes in bioprocess development, there is no mainstream characterization method covering all common modifications theoretically possible on therapeutic proteins that also gives consistent results quickly. Here, we describe a method for rapid and consistent global characterization of leachable metals- or peroxide-stressed immunoglobulin (Ig) G1 monoclonal antibodies (mAbs). Using two independent protease digestions, data-independent acquisition and data-dependent acquisition liquid chromatography high-resolution mass spectrometry, we monitored 55 potential chemical modifications on trastuzumab, a humanized IgG1 mAb. Processing templates including all observed peptides were developed on Skyline to consistently monitor all modifications throughout the stress conditions for both enzymatic digestions. The Global Characterization Data Processing Site, a universal automated data processing application, was created to batch process data, plot modification trends for peptides, generate sortable and downloadable modification tables, and produce Jmol code for three-dimensional structural models of the analyzed protein. In total, 53 sites on the mAb were found to be modified. Oxidation rates generally increased with the peroxide concentration, while leachable metals alone resulted in lower rates of modifications but more oxidative degradants. Multiple chemical modifications were found on IgG1 surfaces known to interact with FcɣRIII, complement protein C1q, and FcRn, potentially affecting activity. The combination of Skyline templates and the Global Characterization Data Processing Site results in a universally applicable assay allowing users to batch process numerous modifications. Applying this new method to stability studies will promote a broader and deeper understanding of stress modifications on therapeutic proteins.

Indexed as

Oxidative StressAntibodies, MonoclonalChromatography, LiquidHumansImmunoglobulin GOxidation-ReductionPeptidesReceptors, IgGTandem Mass SpectrometryAntibodies, MonoclonalFCGR3A protein, humanImmunoglobulin GPeptidesReceptors, IgGdata-dependent acquisition (DDA)data-independent acquisition (DIA)Global characterizationhigh-resolution mass spectrometry (HRMS)immunoglobulin G1 (IgG1)leachable metalsmonoclonal antibody (mAb)oxidative stressperoxidespost-translational modifications (PTM)processing automationproteomicsquantitative proteomics

Identifiers

PMID31156028
PMCPMC6748588
OpenAlexW2948285676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.